High-grade glioma
3 papers
- Animals1
- Cells1
Trial sponsors
Novartis Pharmaceuticals Corporation
Company1 trialPhase 4100 people
Xennials Therapeutics Australia
Company1 trialPhase 1/212 people
Company1 trialPhase 136 people
The Netherlands Cancer Institute
1 trialPhase 3408 people
St. Jude Children's Research Hospital
2 trialsPhase 288 people
Nationwide Children's Hospital
1 trialPhase 2120 people
University of Michigan Rogel Cancer Center
1 trialPhase 23 people
University of California, San Francisco
1 trialPhase 150 people
Latest
4 in 12 monthsFrontiers in Immunology
Towards a personalized perspective on gliomas: an epigenetic-immuno-inflammatory aging framework
Computational studyMechanisms
Neurological Sciences
Efficacy and safety of ketogenic diet in glioblastoma: an updated systematic review and meta-analysis
Meta-analysis of studies in peopleKetogenic diet
Bulletin of Experimental Biology and Medicine
Tumor Cell Lines as a Biosensor Substrate for Pathological Aging and CNS Tumors
Experiments in rat cellsBiomarkers